Following a surgical injury, trauma, burn or bacterial infection, the host undergoes a series of characteristic tissue responses, including anorexia, wasting of skeletal protein and an hepatic """"""""acute-phase"""""""" protein response. Despite considerable evidence that interleukin 1 (IL-1) and cachectin (tumour necrosis factor- alpha), two secretory products of activated blood monocytes and tissue macrophages, play a pivotal role in how the host responds to trauma and infection, there is only scant information regarding the regulation of their biosynthesis in surgery, injury and bacterial infections. Therefore, the in vivo production rate of both IL-1 (alpha and beta) and cachectin will be assessed in hospitalized patients after surgery or thermal injury, and in murine and rat models of trauma, surgical injury and infections. In addition to measuring circulating concentrations, highly specific human and murine cDNA probes for IL-1 (alpha and beta) will be used to assess the quantity of mRNA present in blood monocytes and tissue macrophages from animals subjected to inflammatory stress. To directly determined tissue sources of IL-1 and cachectin production, immunocytochemical techniques will be employed. In addition, despite similarities in the tissue responses to IL-1 and cachectin, little information is currently available about the contribution these two monokines make, singly and together, to the pathophysiologic changes which occur. Therefore, the administration of either neutralizing antibodies to IL-1 (both species) and/or cachectin, or the infusion of recombinant-derived protein, to both healthy and traumatized animals will be performed to assess the quantitative importance these monokines make to either the hepatic acute phase protein, skeletal protein synthesis, or whole body compositional changes which occur. In addition, utilizing a semi-lethal burn and infection model, survival in response to additional IL-1 or cachectin, or to neutralizing antibodies, will be assessed. Such studies will thus provide a more complete understanding of the underlying mechanisms by which IL-1 and cachectin biosynthesis are regulated, as well as their prevalence and importance in clinically-relevant disease. Such investigations will both improve our basic understanding of the metabolic response to surgery and injury as well as provide a theoretical basis for attempts to modify this host response.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM040586-04
Application #
3298303
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1988-08-01
Project End
1993-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Horiguchi, Hiroyuki; Loftus, Tyler J; Hawkins, Russell B et al. (2018) Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy. Front Immunol 9:595
Mira, Juan C; Nacionales, Dina C; Loftus, Tyler J et al. (2018) Mouse Injury Model of Polytrauma and Shock. Methods Mol Biol 1717:1-15
Hawkins, Russell B; Raymond, Steven L; Stortz, Julie A et al. (2018) Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. Front Immunol 9:1511
Stortz, Julie A; Mira, Juan C; Raymond, Steven L et al. (2018) Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients. J Trauma Acute Care Surg 84:342-349
Brakenridge, Scott C; Efron, Philip A; Stortz, Julie A et al. (2018) The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients. J Trauma Acute Care Surg 85:247-255
Stortz, Julie A; Murphy, Tyler J; Raymond, Steven L et al. (2018) Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis. Shock 49:249-258
Raymond, Steven L; Holden, David C; Mira, Juan C et al. (2017) Microbial recognition and danger signals in sepsis and trauma. Biochim Biophys Acta Mol Basis Dis 1863:2564-2573
Stortz, Julie A; Efron, Philip A (2017) Editorial: Myeloid-derived suppressor cells: a new therapeutic target in sepsis patients. J Leukoc Biol 102:185-187
Mira, Juan C; Cuschieri, Joseph; Ozrazgat-Baslanti, Tezcan et al. (2017) The Epidemiology of Chronic Critical Illness After Severe Traumatic Injury at Two Level-One Trauma Centers. Crit Care Med 45:1989-1996
Raymond, Steven L; López, María Cecilia; Baker, Henry V et al. (2017) Unique transcriptomic response to sepsis is observed among patients of different age groups. PLoS One 12:e0184159

Showing the most recent 10 out of 196 publications